This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We’re dedicating today’s top story to the people and publications that we rely on to find the most interesting cardiology stories from across the web. Assuming that you already subscribe to Cardiac Wire , these are the 40 other newsletters, websites, and social media stars to follow if you want to keep up with the latest and greatest in cardiology. I’ll always check the mainstream cardiology news websites ( TCTMD , Medscape , et al.) and the major cardiovascular journals ( JACC , AHA , JAMA Card
Results from the FLASH trial demonstrate the noninferiority of artificial intelligence-based fully automated quantitative coronary angiography (AI-QCA)-assisted PCI compared with optical coherence tomography (OCT)-guided PCI in achieving optimal minimal stent area, with comparable procedural complications, OCT-defined endpoints, and six-month clinical outcomes, according to researchers presenting the findings at TCT 2024.
tim.hodson Wed, 10/30/2024 - 10:00 Oct. 30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S.
Several abstracts presented at TCT 2024, taking place Oct. 27-30 in Washington, DC, used data from ACC’s CathPCI Registry, Chest Pain – MI Registry and the STS/ACC TVT Registry to evaluate institutional volume and failure to rescue in TAVR, outcomes of sequential TAVR and mitral transcatheter edge-to-edge repair (TEER), the impact of coronary artery disease (CAD) and revascularization on health status and more.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Chronic, low-level lead poisoning is a major risk factor for cardiovascular disease in adults and cognitive deficits in children, even at levels previously thought to be safe, Low-level lead poisoning is a risk factor for preterm. Annually 5.5 million deaths from cardiovascular disease attributed to low-level lead poisoning; accounts for a loss of 765 million IQ points in children.
Alternating between sitting and standing at work decreases sedentary behavior, but it has no effect on lowering blood pressure, according to a study led by a West Virginia University epidemiologist. Researchers also found that too much standing during work may have negative effects on cardiovascular health.
(MedPage Today) -- Most patients should not stop taking GLP-1 receptor agonists prior to elective surgery, according to updated guidance from several medical societies, including the American Society of Anesthesiologists (ASA). This recommendation.
124
124
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
(MedPage Today) -- Most patients should not stop taking GLP-1 receptor agonists prior to elective surgery, according to updated guidance from several medical societies, including the American Society of Anesthesiologists (ASA). This recommendation.
New research suggests older adults wait 3-6 months after a heart attack before elective noncardiac surgery to reduce the risk of serious complications like stroke or another heart attack.
(MedPage Today) -- Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered randomized trial, researchers found. Between acute MI patients randomized to colchicine or placebo right after.
(MedPage Today) -- For adolescents, weight loss after bariatric surgery was durable out to 10 years, data from the Teen Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study confirmed. Among 260 adolescents who underwent bariatric surgery.
A heart attack can trigger a desire to get more sleep, allowing the heart to heal and reduce inflammation—and this happens because the heart sends special signals to the brain, according to a new Mount Sinai study.
Research shows that in recent years almost half of all adults in the United States have been living with heart disease, one of the most prominent forms of vascular disease. Vascular disease affects the body’s vast network of blood vessels, veins and arteries.
Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. 22. Of those recipients, 50 hospitals were recognized for delivering superior clinical outcomes in vascular surgery.
Hypertension is the most common cardiovascular disease (CVD) comorbidity seen among dialysis patients globally, according to a study presented at Kidney Week, the annual meeting of the American Society of Nephrology, held from Oct. 23 to 27 in San Diego.
A 69-year-old man with a history of MI and cardiomyopathy presented with 2 days of dyspnea. Regular tachycardia (124 beats per min), diaphoresis, and rales were present. A diagnosis was made.
After a heart attack, aging adults face double or triple the risk of life-threatening complications—like a debilitating stroke or another heart attack—when they move forward with elective noncardiac surgeries too soon, according to new University of Rochester research published in JAMA Surgery.
Every year, thousands of lives are saved with cardiopulmonary resuscitation (CPR). Yet, overall survival among patients with out-of-hospital cardiac arrest is approximately 10%, even in well-performing emergency medical systems. The interventions that are undertaken at the scene of a cardiac arrest are the most likely interventions to improve outcomes: early.
In this week’s View, Dr. Eagle looks at the consequences of discontinuing long-term drug treatment in patients with heart failure and reduced ejection fraction (HFrEF). He then explores the effect of race and sacubitril/valsartan use in HF patients documented in a pooled analysis of the PARADIGM-HF and PARAGON-HF trials.
A federal court has dismissed an antitrust lawsuit filed against Indianapolis based-Indiana University Health. The lawsuit was filed by vascular surgeon Ricardo Vasquez, MD, who alleged the health system engaged in anti-competitive behavior.
A quantitative flow ratio (QFR)-guided strategy did not provide the same prognostic benefits as a fractional flow reserve (FFR)-guided strategy for patients with intermediate coronary stenosis, based on findings from the FAVOR III Europe trial presented at TCT 2024 and simultaneously published in The Lancet.
The goal of the ACURATE IDE trial was to evaluate the Acurate neo2 self-expanding valve compared with a commercially available valve (Sapien or Evolut) among patients with aortic stenosis across the risk spectrum.
An advanced robotic system at The Hospital for Sick Children (SickKids) is changing the way physicians and scientists approach treatments for heart disease.
The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce cardiovascular death, myocardial infarction, stroke, or ischemia-driven revascularization.
There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29 in Annals of Internal Medicine.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
105 
Let's personalize your content